LLY

919.09

+1.78%↑

JNJ

235.07

-0.17%↓

ABBV

204.77

+0.26%↑

NVS

147.72

+1.25%↑

AZN

184.59

+0.67%↑

LLY

919.09

+1.78%↑

JNJ

235.07

-0.17%↓

ABBV

204.77

+0.26%↑

NVS

147.72

+1.25%↑

AZN

184.59

+0.67%↑

LLY

919.09

+1.78%↑

JNJ

235.07

-0.17%↓

ABBV

204.77

+0.26%↑

NVS

147.72

+1.25%↑

AZN

184.59

+0.67%↑

LLY

919.09

+1.78%↑

JNJ

235.07

-0.17%↓

ABBV

204.77

+0.26%↑

NVS

147.72

+1.25%↑

AZN

184.59

+0.67%↑

LLY

919.09

+1.78%↑

JNJ

235.07

-0.17%↓

ABBV

204.77

+0.26%↑

NVS

147.72

+1.25%↑

AZN

184.59

+0.67%↑

Kodu・Aktsiate loetelu・Pulse Biosciences Inc

Pulse Biosciences Inc

Suletud

SektorTervishoid

22.19 -1.81

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

21.77

Max

22.2

Põhinäitajad
By Trading Economics
Sissetulek	2M -17M
Müük	178K 264K
Aktsiakasum	-0.257
Kasumimarginaal	-6,603.409
Töötajad	116
EBITDA	2M -17M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+35.75% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	7. mai 2026

Turustatistika
By TradingEconomics
Turukapital	-179M 958M
Eelmine avamishind	24
Eelmine sulgemishind	22.19

Uudiste sentiment

By Acuity

76%

24%

315 / 350 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

16.59 / 17.17 Toetus ja vastupanu

Pulse Biosciences Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

22. märts 2026, 23:50 UTC

Market Talk

Global Equities Roundup: Market Talk

22. märts 2026, 23:50 UTC

Market Talk

LG Electronics Set to Stage Strong Earnings Rebound in 1Q -- Market Talk

22. märts 2026, 23:49 UTC

Market Talk

Uudisväärsed sündmused

Gold Edges Lower on Prospects of Liquidity-Driven Sales -- Market Talk

22. märts 2026, 23:49 UTC

Market Talk

Uudisväärsed sündmused

Nikkei May Fall as Concerns About Middle East Conflict Persist -- Market Talk

22. märts 2026, 23:49 UTC

Market Talk

Uudisväärsed sündmused

Global Forex and Fixed Income Roundup: Market Talk

22. märts 2026, 23:41 UTC

Market Talk

Uudisväärsed sündmused

Oil Edges Lower as Traders Eye Trump's Deadline to Reopen Strait of Hormuz -- Market Talk

22. märts 2026, 22:57 UTC

Omandamised, ülevõtmised, äriostud

Perseus Mining: Location of Aurum's Discoveries Present Potential Future Synergies

22. märts 2026, 22:56 UTC

Omandamised, ülevõtmised, äriostud

Perseus Mining: Aurum Share Acquisition Cost A$23.69 Million

22. märts 2026, 22:56 UTC

Omandamised, ülevõtmised, äriostud

Perseus Mining: Aurum's Boundiali Gold Project Located to South of Sissingue Gold Mine

22. märts 2026, 22:55 UTC

Omandamised, ülevõtmised, äriostud

Perseus Mining: Participated in Aurum Resources Equity Raising

22. märts 2026, 22:54 UTC

Omandamised, ülevõtmised, äriostud

Perseus Mining: Acquires 9.9% Interest in Aurum Resources

22. märts 2026, 22:22 UTC

Market Talk

Uudisväärsed sündmused

After Selloff, Gold Seen Supported by Strait of Hormuz Deadline -- Market Talk

22. märts 2026, 22:06 UTC

Omandamised, ülevõtmised, äriostud

Synopsys Has Market Value Over $80 Billion; Major Customers Include Nvidia -- WSJ

22. märts 2026, 22:06 UTC

Omandamised, ülevõtmised, äriostud

Activist Elliott Builds Big Stake in Chip-Design Software Maker Synopsys -- WSJ

22. märts 2026, 22:06 UTC

Omandamised, ülevõtmised, äriostud

Activist Elliott Investment Management Has Multibillion-Dollar Investment in Synopsys, Sources Say -- WSJ

22. märts 2026, 22:06 UTC

Omandamised, ülevõtmised, äriostud

Elliott Plans to Push Synopsys to Make More Money From Its Software and Services, Sources Say -- WSJ

22. märts 2026, 21:53 UTC

Tulu

Zijin Gold International Plans 59.2 Tons of Gold Production in 2026; up 12.3% on Year >2259.HK

22. märts 2026, 21:53 UTC

Tulu

Zijin Gold International Rising Gold Prices Supported Results >2259.HK

22. märts 2026, 21:53 UTC

Tulu

Zijin Gold International 2025 Rev $5.38B Vs. $2.99B >2259.HK

22. märts 2026, 21:53 UTC

Tulu

Zijin Gold International 2025 Net $1.60B Vs. Net $481.37M >2259.HK

22. märts 2026, 21:31 UTC

Tulu

China Petroleum & Chemical Plans CNY131.6B-CNY148.6B Capex Spending in 2026>0386.HK

22. märts 2026, 21:31 UTC

Tulu

China Petroleum & Chemical: Decrease in Sales Volumes of Refined Oil Products Also Hurt Results >0386.HK

22. märts 2026, 21:31 UTC

Tulu

China Petroleum & Chemical 2025 Results Weighed by Decrease in Prices of Petroleum, Petrochemical Products>0386.HK

22. märts 2026, 21:31 UTC

Tulu

China Petroleum & Chemical 2025 Rev CNY2.78T Vs. CNY3.07T >0386.HK

22. märts 2026, 21:31 UTC

Tulu

China Petroleum & Chemical 2025 Net CNY32.48B Vs. Net CNY48.94B >0386.HK

22. märts 2026, 21:25 UTC

Market Talk

Uudisväärsed sündmused

Bonds Decoupling From Oil Amid Longer Conflict Fears -- Market Talk

22. märts 2026, 21:22 UTC

Omandamised, ülevõtmised, äriostud

St Barbara: Remarks Follow Recent Inquiries About Simberi's Fuel Stocks

22. märts 2026, 21:21 UTC

Omandamised, ülevõtmised, äriostud

St Barbara: Simberi Currently Uses About 65,000 Liters Per Day For Mining Fleet, Power Generation

22. märts 2026, 21:21 UTC

Market Talk

Revised Fuel Subsidy Mechanism Positive for Ampol, Viva Energy -- Market Talk

22. märts 2026, 21:21 UTC

Omandamised, ülevõtmised, äriostud

St Barbara: Has Been Taking Precaution to Increase Diesel Storage For Several Months

Võrdlus sarnastega

Hinnamuutus

Pulse Biosciences Inc Prognoos

Hinnasiht

By TipRanks

35.75% tõus

12 kuu keskmine prognoos

Keskmine 30 USD 35.75%

Kõrge 30 USD

Madal 30 USD

Põhineb 2 Wall Streeti analüütiku instrumendi Pulse Biosciences Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

2 ratings

Osta

Hoia

Müü

Põhineb 2 analüütiku instrumendi Pulse Biosciences Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

16.59 / 17.17Toetus ja vastupanu

Recent bearish events outweigh bullish events.

Sentiment

By Acuity

315 / 350 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.